Abstract
BackgroundCancer immunotherapy shows insufficient efficacy for low immunogenic tumors. Furthermore, tumors often downregulate antigen and major histocompatibility complex expression to escape recognition by T cells, resulting in insufficient T cell...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have